Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CYB5R3 |
| Upstream (Parents) |
|---|
| (<<) ACTB → CYB5R3 |
| (<<) CFL1 → CYB5R3 |
| Downstream (Children) |
|---|
| CYB5R3 → RRBP1 (>>) |
| CYB5R3 → PEA15 (>>) |
| CYB5R3 → BANF1 (>>) |
| CYB5R3 → NDRG2 (>>) |
| CYB5R3 → CRABP2 (>>) |
| CYB5R3 → EPHX1 (>>) |
| CYB5R3 → BGN (>>) |
| CYB5R3 → CLPTM1 (>>) |
| CYB5R3 → NDUFA4L2 (>>) |
| CYB5R3 → P4HB (>>) |
| CYB5R3 → ITGB4 (>>) |
| CYB5R3 → ARHGDIA (>>) |
| CYB5R3 → CFL1 (>>) |
| CYB5R3 → CD151 (>>) |
| CYB5R3 → ZYX (>>) |
| CYB5R3 → PLEC (>>) |
| CYB5R3 → PLD3 (>>) |
| CYB5R3 → SHC1 (>>) |
| CYB5R3 → WRN (>>) |
| CYB5R3 → POLDIP3 (>>) |
| CYB5R3 → RHOC (>>) |
| CYB5R3 → PKM2 (>>) |
| CYB5R3 → AGAP3 (>>) |
| CYB5R3 → CHCHD10 (>>) |
| CYB5R3 → RBKS (>>) |
| CYB5R3 → LGALS1 (>>) |
| CYB5R3 → TLN1 (>>) |
| CYB5R3 → MRPS15 (>>) |
| CYB5R3 → CAPZB (>>) |
| CYB5R3 → SLC29A1 (>>) |
| CYB5R3 → VKORC1 (>>) |
| CYB5R3 → FXYD5 (>>) |
| CYB5R3 → RRAS (>>) |
| CYB5R3 → PCLO (>>) |
| CYB5R3 → SUMO3 (>>) |
| CYB5R3 → SPTAN1 (>>) |
